期刊文献+

三维适形放疗联合替吉奥同步化疗治疗老年食管癌疗效观察 被引量:38

下载PDF
导出
摘要 目的观察三维适形放疗联合替吉奥同步化疗治疗老年食管癌的疗效。方法 54例老年食管癌患者随机分为观察组(25例)和对照组(29例),观察组采用三维适形放疗联合替吉奥同步化疗,对照组单纯采用三维适形放疗,观察两组疗效、不良反应及患者生存率。结果观察组及对照组有效率分别为68.00%、58.62%,两组比较,P<0.05。观察组及对照组不良反应发生率分别为16.00%、20.69%,两组比较,P>0.05。观察组1、2年患者生存率分别为80.0%、53.9%,对照组为55.2%、29.6%,两组比较,P均<0.05。结论三维适形放疗联合替吉奥同步化疗治疗老年食管癌疗效较好,且不增加不良反应。
出处 《山东医药》 CAS 北大核心 2016年第3期70-71,共2页 Shandong Medical Journal
基金 阜阳市卫生局医学科学研究基金资助项目(2012FYKZ008)
  • 相关文献

参考文献14

  • 1Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
  • 2Chen W,He Y,Zheng R,et al.Esophageal cancer incidence and mortality in China,2009[J].J Thorac Dis,2013,5(1):19-26.
  • 3Song QK,Li J,Jiang HD,et al.Esophageal cancer mortality during 2004-2009 in Yanting County,China[J].Asian Pac J Cancer Prev,2012,13(10):5003-5006.
  • 4王向前,蔡晶,顾红芳,夏小春.放疗同步联合替吉奥治疗老年食管癌的临床观察[J].临床肿瘤学杂志,2013,18(5):434-437. 被引量:24
  • 5Iwase H,Shimada M,Tsuzuki T,et al.Concurrent chemoradiotherapy with a novel fluoropyrimidine,S-1,and cisplatin for locally advanced esophageal cancer:long-term results of a phaseⅡtrial[J].Oncology(Williston Park),2013,84(6):342-349.
  • 6Kurokawa Y,Shibata T,Ando N,et al.Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer:RECIST or histology[J].Ann Surg Oncol,2013,20(9):3009-3014.
  • 7张清琴,王军民,杨萌,王荦楠,崔艳慧,李小瑞,靳彩玲.替吉奥联合调强放疗对食管癌再程放疗的疗效观察[J].山东医药,2015,55(1):52-53. 被引量:13
  • 8郭浩,冉瑞智.三维适型放疗同步替吉奥化疗治疗Ⅱ~Ⅲ期食管癌19例疗效观察[J].山东医药,2015,55(29):107-107. 被引量:7
  • 9Chang H,Shin SK,Cho BC,et al.A prospective phaseⅡtrial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer[J].Cancer Chemother Pharmacol,2014,73(4):665-671.
  • 10Park SH,Ryu JS,Oh SJ,et al.The feasibility of(18)f-fluorothymidine PET for prediction of tumor response after induction chemotherapy followed by chemoradiotherapy with S-1/Oxaliplatin in patients with resectable esophageal cancer[J].Nucl Med Mol Imaging,2012,46(1):57-64.

二级参考文献37

  • 1张力建.老年性食管癌的诊治现状[J].中华老年多器官疾病杂志,2005,4(3):172-174. 被引量:21
  • 2韩文周,李东峰,张海旺,杜俊普,刘彦中,程治强.63例75岁以上高龄食管癌贲门癌患者外科治疗的临床分析[J].中国民康医学,2007,19(7):272-272. 被引量:15
  • 3殷蔚伯,李晔雄.肿瘤放射治疗手册[M].北京:中国协和医科大学出版社,2009:114.
  • 4Cooper JS, Guo MD, Herskovie A, et al. Chemoradiotherapy of locally advanced esophageal cancer= long term follow-up of a prospective randomized trial(RTOG 85-01) EJ~. JAMA, 1999, 281(17) :1623-1627.
  • 5Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer[J]. Semin Radiat Onco1,2007,17 ( 1 ) :2 - 9.
  • 6Wakui R, Yamashita H, Okuma K, et al. Esophageal cancer: definitive chemoradiotherapy for elderly patients [ J]. Dis Esophagus ,2010,23 (7) :572 - 579.
  • 7Cooper JS,Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer:long-time follow-up of a pro- spective randomized trial. ( RTOG85-01 ) [ J ]. JAMA, 1999,281 (17) : 1623 - 1627.
  • 8Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagous [ J ]. Cochrane Database Syst Rev, 2006, 25 ( 1 ) : CD002092.
  • 9Satoh T,Sakata Y. S-I for the treatment of gastrointestinal cancer [ J ]. Expert Opin Pharmaeother,2012,13 ( 13 ) : 1943 - 1959.
  • 10Shirasaka T. Development history and concept of an oral antiean- eer agent S-I ( TS-1 ) : its clinical usefulness and future vistas[J].Jpn J Clin Oncol,2009,39( 1 ) :2 - 15.

共引文献62

同被引文献253

引证文献38

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部